I seem to recall Marty telling me by phone when I asked him around 2 to 3 years.
I cannot be sure I am quoting him 100% accurately therefore I would suggest to call him and ask him directly.
If I have time in the next few days I may do so, but I would encourage others to also.
What I also recall is the reason for such a short duration is that IIb trials roll into (overlap) with phase III and a reduced endpoint requirement based on Orphan drug designation (to come as part of IND approval) is already agreed with the FDA.
planet
timeline, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.3¢ |
Change
-0.013(4.39%) |
Mkt cap ! $407.2M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.3¢ | $487.7K | 1.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 440533 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 235918 | 20 |
View Market Depth
| Last trade - 12.16pm 01/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |